Why did JPMorgan spark rally in quantum computing stocks?
How is the UK creating 400,000 green energy jobs?
What caused Tesla CEO Elon Musk’s White House snub?
Why are AI startups leasing luxury apartments in SF?
How did Nvidia’s US wafer production impact AI industry?
Why did Nexperia China defy Dutch chipmaker headquarters?
What’s driving gold’s record high prices recently?
OS Therapies Reports Strong 2-Year Survival Data For Bone Cancer Immunotherapy Candidate
benzinga.com/news/health-care/25/10/48149412/os-therapies-reports-strong-2-year-survival-data-for-bone-cancer-immunotherapy-candidate
OS Therapies Inc. (NYSE:OSTX), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, released survival data on Friday from the Phase 2b trial of its off-the-shelf immunotherapy candidate, OST-HER2, for pulmonary metastatic osteosarcoma, an aggressive…
This story appeared on benzinga.com, 2025-10-10 14:40:05.